Jake Remaly

2 months ago | medscape.com | Jake Remaly

Pills can cure infection with the hepatitis C virus (HCV), but getting the medication to patients who need treatment can be a challenge. Many patients with HCV use drugs such as methamphetamine or heroin and were exposed to the virus by sharing needles. Lack of housing, difficulty getting to appointments, and mistrust of the healthcare system are potential barriers to care.

Dec 8, 2024 | univadis.es | Jake Remaly

Editado por Jake RemalyCONCLUSIÓN PRÁCTICAEl uso de mascarilla facial durante las inyecciones intravítreas de anti-VEGF se asoció con una frecuencia similar de endoftalmitis en comparación con la falta de uso de inyecciones, en un amplio estudio retrospectivo.

Nov 25, 2024 | mdedge.com | Jake Remaly

’Tis the season for recognizing seasonal affective disorder (SAD). Just don’t expect to find SAD in diagnostic handbooks. As a memorable term, SAD “stuck in the general public, and to some extent among health professionals,” said Scott Patten, MD, PhD, professor of psychiatry and epidemiology at the University of Calgary in Alberta, Canada.

Nov 6, 2024 | mdedge.com | Jake Remaly

TOPLINE:Weight loss interventions using medication or behavioral changes can improve insulin resistance, hormonal markers, and menstrual frequency in women with polycystic ovary syndrome (PCOS), according to a new meta-analysis. Losing weight may not significantly reduce hirsutism or improve quality of life in women with the condition, however. METHODOLOGY:Researchers systematically reviewed randomized controlled trials comparing weight loss interventions to usual care in women with PCOS.

Oct 28, 2024 | mdedge.com | Jake Remaly

TOPLINE:  The use of a levonorgestrel-releasing intrauterine system (LNG-IUS) is associated with an increased risk for breast cancer. An analysis by Danish researchers found 14 extra cases of breast cancer per 10,000 women using this type of an intrauterine device (IUD) vs women not using hormonal contraceptives. METHODOLOGY: The investigators used nationwide registries in Denmark to identify all women aged 15-49 years who were first-time initiators of any LNG-IUS between 2000 and 2019.